Maning, Gabe .
HRN: 14-52-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2024
CEFUROXIME 750MG (VIAL)
10/27/2024
11/03/2024
IV
550mg
Q8
PCAP
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes